⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28940613 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL9698956 | 0.76 | CA2 (0.36) | — | |
| SCHEMBL28433794 | 0.76 | CA2 (0.36) | — | |
| SCHEMBL22467467 | 0.74 | ALDH1A1 (0.36) | — | |
| SCHEMBL28237915 | 0.74 | HCAR2 (0.43) | — | |
| SCHEMBL28433795 | 0.70 | LDHA (0.35) | — | |
| SCHEMBL29175484 | 0.70 | TSHR (0.34) | — | |
| SCHEMBL31547589 | 0.69 | ALDH1A1 (0.32) | — | |
| SCHEMBL20936309 | 0.69 | ALDH1A1 (0.37) | — | |
| SCHEMBL3195205 | 0.65 | CA2 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025070241-A1 | COMPOUND OR SALT THEREOF, AND METHOD FOR PRODUCING THE SAME | 藤本化学製品株式会社 | 2025-04-03 | — | — | WO | disclosed |
| EP-2219448-A1 | THERAPEUTIC COMPOUNDS AND THEIR USE IN TREATING DISEASES AND DISORDERS | Myriad Pharmaceuticals, Inc. (US) | 2010-08-25 | — | — | EP | disclosed |
| WO-2009065035-A1 | THERAPEUTIC COMPOUNDS AND THEIR USE IN TREATING DISEASES AND DISORDERS | MYRIAD GENETICS, INC. (US) | 2009-05-22 | — | — | WO | disclosed |
| CN-101155800-A | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | ASTRAZENECA AB (SE) | 2008-04-02 | — | — | CN | disclosed |